Global Subcutaneous Medicine Delivery Devices Market Research Report 2023

Report ID: 1242455 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Subcutaneous Medicine Delivery Devices Market Overview
    1.1 Product Overview and Scope of Subcutaneous Medicine Delivery Devices
    1.2 Subcutaneous Medicine Delivery Devices Segment by Type
        1.2.1 Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Implantable Subcutaneous Medicine Delivery Device
        1.2.3 Injection Type Subcutaneous Medicine Delivery Device
    1.3 Subcutaneous Medicine Delivery Devices Segment by Application
        1.3.1 Global Subcutaneous Medicine Delivery Devices Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Subcutaneous Medicine Delivery Devices Market Size Estimates and Forecasts
        1.4.1 Global Subcutaneous Medicine Delivery Devices Revenue 2017-2028
        1.4.2 Global Subcutaneous Medicine Delivery Devices Sales 2017-2028
        1.4.3 Subcutaneous Medicine Delivery Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Subcutaneous Medicine Delivery Devices Market Competition by Manufacturers
    2.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Subcutaneous Medicine Delivery Devices Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Subcutaneous Medicine Delivery Devices Manufacturing Sites, Area Served, Product Type
    2.5 Subcutaneous Medicine Delivery Devices Market Competitive Situation and Trends
        2.5.1 Subcutaneous Medicine Delivery Devices Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Subcutaneous Medicine Delivery Devices Players Market Share by Revenue
        2.5.3 Global Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Medicine Delivery Devices Retrospective Market Scenario by Region
    3.1 Global Subcutaneous Medicine Delivery Devices Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Subcutaneous Medicine Delivery Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
        3.3.1 North America Subcutaneous Medicine Delivery Devices Sales by Country
        3.3.2 North America Subcutaneous Medicine Delivery Devices Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
        3.4.1 Europe Subcutaneous Medicine Delivery Devices Sales by Country
        3.4.2 Europe Subcutaneous Medicine Delivery Devices Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Subcutaneous Medicine Delivery Devices Market Facts & Figures by Region
        3.5.1 Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region
        3.5.2 Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
        3.6.1 Latin America Subcutaneous Medicine Delivery Devices Sales by Country
        3.6.2 Latin America Subcutaneous Medicine Delivery Devices Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
        3.7.1 Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country
        3.7.2 Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Subcutaneous Medicine Delivery Devices Historic Market Analysis by Type
    4.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2017-2022)
    4.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2017-2022)
    4.3 Global Subcutaneous Medicine Delivery Devices Price by Type (2017-2022)
5 Global Subcutaneous Medicine Delivery Devices Historic Market Analysis by Application
    5.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2017-2022)
    5.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2017-2022)
    5.3 Global Subcutaneous Medicine Delivery Devices Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Boehringer Ingelheim
        6.1.1 Boehringer Ingelheim Corporation Information
        6.1.2 Boehringer Ingelheim Description and Business Overview
        6.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolio
        6.1.5 Boehringer Ingelheim Recent Developments/Updates
    6.2 Eli Lily
        6.2.1 Eli Lily Corporation Information
        6.2.2 Eli Lily Description and Business Overview
        6.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolio
        6.2.5 Eli Lily Recent Developments/Updates
    6.3 Galaxo
        6.3.1 Galaxo Corporation Information
        6.3.2 Galaxo Description and Business Overview
        6.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolio
        6.3.5 Galaxo Recent Developments/Updates
    6.4 HMD pharmaceuticals
        6.4.1 HMD pharmaceuticals Corporation Information
        6.4.2 HMD pharmaceuticals Description and Business Overview
        6.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolio
        6.4.5 HMD pharmaceuticals Recent Developments/Updates
    6.5 Merck
        6.5.1 Merck Corporation Information
        6.5.2 Merck Description and Business Overview
        6.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Merck Subcutaneous Medicine Delivery Devices Product Portfolio
        6.5.5 Merck Recent Developments/Updates
    6.6 Novartis
        6.6.1 Novartis Corporation Information
        6.6.2 Novartis Description and Business Overview
        6.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Novartis Subcutaneous Medicine Delivery Devices Product Portfolio
        6.6.5 Novartis Recent Developments/Updates
    6.7 Novo Nordisk
        6.6.1 Novo Nordisk Corporation Information
        6.6.2 Novo Nordisk Description and Business Overview
        6.6.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolio
        6.7.5 Novo Nordisk Recent Developments/Updates
    6.8 Pfizer
        6.8.1 Pfizer Corporation Information
        6.8.2 Pfizer Description and Business Overview
        6.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolio
        6.8.5 Pfizer Recent Developments/Updates
    6.9 Sanofi
        6.9.1 Sanofi Corporation Information
        6.9.2 Sanofi Description and Business Overview
        6.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolio
        6.9.5 Sanofi Recent Developments/Updates
    6.10 Teva Pharmaceutical
        6.10.1 Teva Pharmaceutical Corporation Information
        6.10.2 Teva Pharmaceutical Description and Business Overview
        6.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolio
        6.10.5 Teva Pharmaceutical Recent Developments/Updates
    6.11 Zogenix
        6.11.1 Zogenix Corporation Information
        6.11.2 Zogenix Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolio
        6.11.5 Zogenix Recent Developments/Updates
    6.12 BD
        6.12.1 BD Corporation Information
        6.12.2 BD Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 BD Subcutaneous Medicine Delivery Devices Product Portfolio
        6.12.5 BD Recent Developments/Updates
    6.13 Insulet Corporation
        6.13.1 Insulet Corporation Corporation Information
        6.13.2 Insulet Corporation Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.13.3 Insulet Corporation Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolio
        6.13.5 Insulet Corporation Recent Developments/Updates
    6.14 Enable Injections
        6.14.1 Enable Injections Corporation Information
        6.14.2 Enable Injections Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.14.3 Enable Injections Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolio
        6.14.5 Enable Injections Recent Developments/Updates
    6.15 West Pharmaceutical Services
        6.15.1 West Pharmaceutical Services Corporation Information
        6.15.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.15.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolio
        6.15.5 West Pharmaceutical Services Recent Developments/Updates
    6.16 Ypsomed AG
        6.16.1 Ypsomed AG Corporation Information
        6.16.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.16.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolio
        6.16.5 Ypsomed AG Recent Developments/Updates
    6.17 Elcam Medical
        6.17.1 Elcam Medical Corporation Information
        6.17.2 Elcam Medical Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.17.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolio
        6.17.5 Elcam Medical Recent Developments/Updates
    6.18 Amgen
        6.18.1 Amgen Corporation Information
        6.18.2 Amgen Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.18.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Amgen Subcutaneous Medicine Delivery Devices Product Portfolio
        6.18.5 Amgen Recent Developments/Updates
    6.19 Wilhelm Haselmeier
        6.19.1 Wilhelm Haselmeier Corporation Information
        6.19.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Description and Business Overview
        6.19.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolio
        6.19.5 Wilhelm Haselmeier Recent Developments/Updates
7 Subcutaneous Medicine Delivery Devices Manufacturing Cost Analysis
    7.1 Subcutaneous Medicine Delivery Devices Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
    7.4 Subcutaneous Medicine Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Subcutaneous Medicine Delivery Devices Distributors List
    8.3 Subcutaneous Medicine Delivery Devices Customers
9 Subcutaneous Medicine Delivery Devices Market Dynamics
    9.1 Subcutaneous Medicine Delivery Devices Industry Trends
    9.2 Subcutaneous Medicine Delivery Devices Market Drivers
    9.3 Subcutaneous Medicine Delivery Devices Market Challenges
    9.4 Subcutaneous Medicine Delivery Devices Market Restraints
10 Global Market Forecast
    10.1 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Type (2023-2028)
    10.2 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Application (2023-2028)
    10.3 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Subcutaneous Medicine Delivery Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Subcutaneous Medicine Delivery Devices Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Subcutaneous Medicine Delivery Devices Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Subcutaneous Medicine Delivery Devices Average Price (K USD/K Units) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Subcutaneous Medicine Delivery Devices Manufacturing Sites and Area Served
    Table 11. Manufacturers Subcutaneous Medicine Delivery Devices Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Subcutaneous Medicine Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Medicine Delivery Devices as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Subcutaneous Medicine Delivery Devices Sales by Region (2017-2022) & (K Units)
    Table 16. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2017-2022)
    Table 17. Global Subcutaneous Medicine Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2017-2022)
    Table 19. North America Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 20. North America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
    Table 21. North America Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 23. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
    Table 25. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
    Table 33. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 39. Global Subcutaneous Medicine Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 40. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2017-2022)
    Table 41. Global Subcutaneous Medicine Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Subcutaneous Medicine Delivery Devices Revenue Share by Type (2017-2022)
    Table 43. Global Subcutaneous Medicine Delivery Devices Price by Type (2017-2022) & (K USD/K Units)
    Table 44. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Application (2017-2022)
    Table 45. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2017-2022)
    Table 46. Global Subcutaneous Medicine Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Subcutaneous Medicine Delivery Devices Revenue Share by Application (2017-2022)
    Table 48. Global Subcutaneous Medicine Delivery Devices Price by Application (2017-2022) & (K USD/K Units)
    Table 49. Boehringer Ingelheim Corporation Information
    Table 50. Boehringer Ingelheim Description and Business Overview
    Table 51. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 52. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product
    Table 53. Boehringer Ingelheim Recent Developments/Updates
    Table 54. Eli Lily Corporation Information
    Table 55. Eli Lily Description and Business Overview
    Table 56. Eli Lily Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 57. Eli Lily Subcutaneous Medicine Delivery Devices Product
    Table 58. Eli Lily Recent Developments/Updates
    Table 59. Galaxo Corporation Information
    Table 60. Galaxo Description and Business Overview
    Table 61. Galaxo Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 62. Galaxo Subcutaneous Medicine Delivery Devices Product
    Table 63. Galaxo Recent Developments/Updates
    Table 64. HMD pharmaceuticals Corporation Information
    Table 65. HMD pharmaceuticals Description and Business Overview
    Table 66. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 67. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product
    Table 68. HMD pharmaceuticals Recent Developments/Updates
    Table 69. Merck Corporation Information
    Table 70. Merck Description and Business Overview
    Table 71. Merck Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 72. Merck Subcutaneous Medicine Delivery Devices Product
    Table 73. Merck Recent Developments/Updates
    Table 74. Novartis Corporation Information
    Table 75. Novartis Description and Business Overview
    Table 76. Novartis Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 77. Novartis Subcutaneous Medicine Delivery Devices Product
    Table 78. Novartis Recent Developments/Updates
    Table 79. Novo Nordisk Corporation Information
    Table 80. Novo Nordisk Description and Business Overview
    Table 81. Novo Nordisk Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 82. Novo Nordisk Subcutaneous Medicine Delivery Devices Product
    Table 83. Novo Nordisk Recent Developments/Updates
    Table 84. Pfizer Corporation Information
    Table 85. Pfizer Description and Business Overview
    Table 86. Pfizer Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 87. Pfizer Subcutaneous Medicine Delivery Devices Product
    Table 88. Pfizer Recent Developments/Updates
    Table 89. Sanofi Corporation Information
    Table 90. Sanofi Description and Business Overview
    Table 91. Sanofi Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 92. Sanofi Subcutaneous Medicine Delivery Devices Product
    Table 93. Sanofi Recent Developments/Updates
    Table 94. Teva Pharmaceutical Corporation Information
    Table 95. Teva Pharmaceutical Description and Business Overview
    Table 96. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 97. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product
    Table 98. Teva Pharmaceutical Recent Developments/Updates
    Table 99. Zogenix Corporation Information
    Table 100. Zogenix Description and Business Overview
    Table 101. Zogenix Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 102. Zogenix Subcutaneous Medicine Delivery Devices Product
    Table 103. Zogenix Recent Developments/Updates
    Table 104. BD Corporation Information
    Table 105. BD Description and Business Overview
    Table 106. BD Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 107. BD Subcutaneous Medicine Delivery Devices Product
    Table 108. BD Recent Developments/Updates
    Table 109. Insulet Corporation Corporation Information
    Table 110. Insulet Corporation Description and Business Overview
    Table 111. Insulet Corporation Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 112. Insulet Corporation Subcutaneous Medicine Delivery Devices Product
    Table 113. Insulet Corporation Recent Developments/Updates
    Table 114. Enable Injections Corporation Information
    Table 115. Enable Injections Description and Business Overview
    Table 116. Enable Injections Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 117. Enable Injections Subcutaneous Medicine Delivery Devices Product
    Table 118. Enable Injections Recent Developments/Updates
    Table 119. West Pharmaceutical Services Corporation Information
    Table 120. West Pharmaceutical Services Description and Business Overview
    Table 121. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 122. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product
    Table 123. West Pharmaceutical Services Recent Developments/Updates
    Table 124. Ypsomed AG Corporation Information
    Table 125. Ypsomed AG Description and Business Overview
    Table 126. Ypsomed AG Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 127. Ypsomed AG Subcutaneous Medicine Delivery Devices Product
    Table 128. Ypsomed AG Recent Developments/Updates
    Table 129. Elcam Medical Corporation Information
    Table 130. Elcam Medical Description and Business Overview
    Table 131. Elcam Medical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 132. Elcam Medical Subcutaneous Medicine Delivery Devices Product
    Table 133. Elcam Medical Recent Developments/Updates
    Table 134. Amgen Corporation Information
    Table 135. Amgen Description and Business Overview
    Table 136. Amgen Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 137. Amgen Subcutaneous Medicine Delivery Devices Product
    Table 138. Amgen Recent Developments/Updates
    Table 139. Wilhelm Haselmeier Corporation Information
    Table 140. Wilhelm Haselmeier Description and Business Overview
    Table 141. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
    Table 142. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product
    Table 143. Wilhelm Haselmeier Recent Developments/Updates
    Table 144. Production Base and Market Concentration Rate of Raw Material
    Table 145. Key Suppliers of Raw Materials
    Table 146. Subcutaneous Medicine Delivery Devices Distributors List
    Table 147. Subcutaneous Medicine Delivery Devices Customers List
    Table 148. Subcutaneous Medicine Delivery Devices Market Trends
    Table 149. Subcutaneous Medicine Delivery Devices Market Drivers
    Table 150. Subcutaneous Medicine Delivery Devices Market Challenges
    Table 151. Subcutaneous Medicine Delivery Devices Market Restraints
    Table 152. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Type (2023-2028) & (K Units)
    Table 153. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Type (2023-2028)
    Table 154. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 155. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Type (2023-2028)
    Table 156. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Application (2023-2028) & (K Units)
    Table 157. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Application (2023-2028)
    Table 158. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 159. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Application (2023-2028)
    Table 160. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)
    Table 161. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Region (2023-2028)
    Table 162. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 163. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Region (2023-2028)
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Subcutaneous Medicine Delivery Devices
    Figure 2. Global Subcutaneous Medicine Delivery Devices Market Share by Type in 2021 & 2028
    Figure 3. Implantable Subcutaneous Medicine Delivery Device Product Picture
    Figure 4. Injection Type Subcutaneous Medicine Delivery Device Product Picture
    Figure 5. Global Subcutaneous Medicine Delivery Devices Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Others
    Figure 9. Global Subcutaneous Medicine Delivery Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Subcutaneous Medicine Delivery Devices Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Subcutaneous Medicine Delivery Devices Sales (2017-2028) & (K Units)
    Figure 12. Subcutaneous Medicine Delivery Devices Sales Share by Manufacturers in 2021
    Figure 13. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Subcutaneous Medicine Delivery Devices Players: Market Share by Revenue in 2021
    Figure 15. Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2017-2022)
    Figure 17. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region in 2021
    Figure 18. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2017-2022)
    Figure 19. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region in 2021
    Figure 20. United States Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Taiwan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Colombia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Subcutaneous Medicine Delivery Devices by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Subcutaneous Medicine Delivery Devices
    Figure 45. Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
    Figure 46. Subcutaneous Medicine Delivery Devices Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Frequently Asked Questions
Subcutaneous Medicine Delivery Devices report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Subcutaneous Medicine Delivery Devices report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Subcutaneous Medicine Delivery Devices report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports